Correlation Between Visa and Evaxion Biotech

Can any of the company-specific risk be diversified away by investing in both Visa and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Evaxion Biotech AS, you can compare the effects of market volatilities on Visa and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Evaxion Biotech.

Diversification Opportunities for Visa and Evaxion Biotech

-0.87

Correlation Coefficient

Visa  Evaxion Biotech

Pay attention - limited upside

The 3 months correlation between Visa and Evaxion is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Visa i.e., Visa and Evaxion Biotech go up and down completely randomly.

Pair Corralation between Visa and Evaxion Biotech

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.23 times more return on investment than Evaxion Biotech. However, Visa Class A is 4.35 times less risky than Evaxion Biotech. It trades about 0.11 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.26 per unit of risk. If you would invest  28,992  in Visa Class A on September 15, 2024 and sell it today you would earn a total of  2,482  from holding Visa Class A or generate 8.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Visa Class A  vs.  Evaxion Biotech AS

Visa Class A

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Evaxion Biotech AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evaxion Biotech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Visa and Evaxion Biotech

The main advantage of trading using opposite Visa and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.

The idea behind Visa Class A and Evaxion Biotech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.